Biotech · Private company · Mcallen, TX, US
Sur180 Therapeutics, LLC
Track this companyFree. Adds Sur180 Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Phase II- Repurposing CRH antagonists for the treatment of endometriosisFiscal year 2026 · $1.1MNIH RePORTER 5R44HD109055-03 · fetched Nov 12, 2026
- Phase II- Repurposing CRH antagonists for the treatment of endometriosisFiscal year 2025 · $1.2MNIH RePORTER 2R44HD109055-02A1 · fetched Nov 12, 2026